Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enforcement Roundup: Spiked Imports, UK Ad Claims

This article was originally published in The Tan Sheet

Executive Summary

Fluoxetine found in spiked imports; Life Support needs some; Abbott sensor glucose test claim stands in UK; and SIS Go comparison claim stops

You may also be interested in...



Abbott Meets UK Claim On OTC Glucose Test Time But Misses On Finger Prick

The firm substantiated the test quickly produces glucose readings for users, but misled consumers by explaining the finger-prick part of the process on an FAQ page accessible with multiple clicks past the brand's website homepage. FreeStyle Libre features a sensor that attaches to skin on the back of the arm and a wireless device that reads information from the sensors.

Abbott Meets UK Claim On OTC Glucose Test Time But Misses On Finger Prick

The firm substantiated the test quickly produces glucose readings for users, but misled consumers by explaining the finger-prick part of the process on an FAQ page accessible with multiple clicks past the brand's website homepage. FreeStyle Libre features a sensor that attaches to skin on the back of the arm and a wireless device that reads information from the sensors.

Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use

The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS108029

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel